Not Tagged
bayer
['bayer']
bayer oncology will be at #aacr23, sharing preclinical results of a highly selective inhibitor for cancer immuno-therapy. abstract: nd04, oral session #immunooncology #cancerresearch
Driving innovation in cancer care for patients.

By following this account you confirm that you are an HCP & accept our community guidelines: https://t.co/iYZUrNHHuk